8AG6 image
Deposition Date 2022-07-19
Release Date 2023-01-25
Last Version Date 2024-07-24
Entry Detail
PDB ID:
8AG6
Title:
human MutSalpha (MSH2/MSH6) binding to DNA with a GT mismatch
Biological Source:
Source Organism:
Host Organism:
Method Details:
Experimental Method:
Resolution:
2.80 Å
Aggregation State:
PARTICLE
Reconstruction Method:
SINGLE PARTICLE
Macromolecular Entities
Polymer Type:polypeptide(L)
Molecule:DNA mismatch repair protein Msh2
Gene (Uniprot):MSH2
Chain IDs:A
Chain Length:934
Number of Molecules:1
Biological Source:Homo sapiens
Polymer Type:polypeptide(L)
Molecule:DNA mismatch repair protein Msh6
Gene (Uniprot):MSH6
Chain IDs:B
Chain Length:1414
Number of Molecules:1
Biological Source:Homo sapiens
Polymer Type:polydeoxyribonucleotide
Molecule:DNA (50-MER)
Chain IDs:C (auth: E)
Chain Length:50
Number of Molecules:1
Biological Source:synthetic construct
Polymer Type:polydeoxyribonucleotide
Molecule:DNA (50-MER)
Chain IDs:D (auth: F)
Chain Length:50
Number of Molecules:1
Biological Source:synthetic construct
Primary Citation
Unexpected moves: a conformational change in MutS alpha enables high-affinity DNA mismatch binding.
Nucleic Acids Res. 51 1173 1188 (2023)
PMID: 36715327 DOI: 10.1093/nar/gkad015

Abstact

The DNA mismatch repair protein MutSα recognizes wrongly incorporated DNA bases and initiates their correction during DNA replication. Dysfunctions in mismatch repair lead to a predisposition to cancer. Here, we study the homozygous mutation V63E in MSH2 that was found in the germline of a patient with suspected constitutional mismatch repair deficiency syndrome who developed colorectal cancer before the age of 30. Characterization of the mutant in mouse models, as well as slippage and repair assays, shows a mildly pathogenic phenotype. Using cryogenic electron microscopy and surface plasmon resonance, we explored the mechanistic effect of this mutation on MutSα function. We discovered that V63E disrupts a previously unappreciated interface between the mismatch binding domains (MBDs) of MSH2 and MSH6 and leads to reduced DNA binding. Our research identifies this interface as a 'safety lock' that ensures high-affinity DNA binding to increase replication fidelity. Our mechanistic model explains the hypomorphic phenotype of the V63E patient mutation and other variants in the MBD interface.

Legend

Protein

Chemical

Disease

Primary Citation of related structures